Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04985812 · ClinicalTrials.gov registry record · Phase 1

A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis

A Phase 1 study of Rheumatoid Arthritis, sponsored by Janssen Research & Development.

Completed
Registry status
Phase 1
Development phase
44
Enrollment target
11
Study locations

NCT04985812 is a Phase 1 study of Rheumatoid Arthritis that has completed, run by Janssen Research & Development. The registered enrollment target is 44 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 11 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04985812, a Phase 1 study of Rheumatoid Arthritis, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
Phase 1
Development phase
44 participants
Enrollment target
11
Study locations

Study Summary

The purpose of this study is to evaluate safety and tolerability of JNJ-67484703 administrations in participants with active rheumatoid arthritis (RA).

Conditions Studied

Rheumatoid Arthritis

Interventions

  • DRUG Placebo
  • DRUG JNJ-67484703

Study Locations (11)

Other

  • Arensia Exploratory Medicine - Tbilisi
  • Budai Irgalmasrendi Korhaz - Budapest
  • Clinexpert Kft - Gyöngyös
  • CRU Hungary Kft. - Kistarcsa
  • Arensia Exploratory Medicine - Chisinau
  • Hosp Univ A Coruna - A Coruña
  • Hosp. Clinico San Carlos - Madrid
  • Hosp. Univ. 12 de Octubre - Madrid
  • ARENSIA Exploratory Medicine Unit - Kiev

Alabama

  • Pinnacle Research Group, LLC - Anniston

Illinois

  • GCSP/CIS Orland Park - Orland Park

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2021-10-18
Est. Completion 2023-05-18
Phase Phase 1

Sponsor

Janssen Research & Development

593 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04985812

The ClinicalTrials.gov registry entry for NCT04985812 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT04985812 reports 11 study locations spanning 3 distinct geographic areas - top geographies include Other, Alabama, Illinois.

Frequently Asked Questions

What is clinical trial NCT04985812 about?

NCT04985812 is a clinical study titled "A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis". The purpose of this study is to evaluate safety and tolerability of JNJ-67484703 administrations in participants with active rheumatoid arthritis (RA).

What is the current status of trial NCT04985812?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2021-10-18. Estimated completion is 2023-05-18.

What conditions does trial NCT04985812 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT04985812?

The interventions under investigation include: Placebo (DRUG), JNJ-67484703 (DRUG).

Who is sponsoring clinical trial NCT04985812?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04985812 being conducted?

This trial has 11 study locations across Alabama, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.